Northern Arizona University

Research Team Sees Major Shift in Relationship Between State-by-State Traffic and COVID-19 Cases, Offering Insights Into Outcomes of Lockdown Policies

“In many states, traffic appears to be a leading indicator, increasing first, with COVID-19 cases rising after a delay of up to 11 days,” said professor Kevin Gurney, head of the NAU research group analyzing the data.
9-Jun-2020 4:30 PM EDT, by Northern Arizona University

Newswise — A research team at Northern Arizona University has been exploring the relationship between new data on daily traffic and the number of COVID-19 cases in the United States. The analysis shows that prior to the end of March, U.S. traffic activity—a useful proxy for a return to pre-COVID economic activity—declined rapidly as the number of COVID-19 cases increased. However, since that time, traffic activity and COVID-19 cases have been exhibiting strong regional patterns, with states such as California and Texas showing traffic increases followed by a rise in COVID-19 cases. Other states such as New York and New Jersey, by contrast, show a rise in traffic activity but a decline in COVID-19 cases.

“During March, the country appeared to move as one, with traffic activity declining dramatically as COVID-19 cases increased. From April, that began to break down. Now we see traffic activity increasing everywhere, but with a very different COVID-19 trend from state to state,” said lead research scientist Pawlok Dass, a postdoctoral scholar in NAU’s School of Informatics, Computing, and Cyber Systems.

The team used newly available traffic data from StreetLight, a platform that estimates the number of Vehicle Miles Travelled (VMT) using anonymized location data from smartphone and navigation devices. After aggregating the original county-scale data to the state-scale, the team combined the daily, state-scale VMT and COVID-19 statistics with daily COVID-19 data made available by The New York Times based on reports from state and local health agencies to explore to what extent traffic activity might act as a proxy for the spread of COVID-19.

“The availability of these types of mobility data have been one of the positive outcomes of this difficult period,” Dass said. “Our ability to understand elements of human activity in response to this pandemic has been advanced significantly by data such as what we are getting from StreetLight.” 

In addition to the different state-by-state trends in relation to traffic activity, the state-by-state breakdown reveals that some states show a strong time lag between traffic and COVID-19.

“In many states, traffic appears to be a leading indicator, increasing first, with COVID-19 cases rising after a delay of up to 11 days,” said professor Kevin Gurney, head of the NAU research group analyzing the data. “Notable exceptions to this are New York, New Jersey, Pennsylvania and Massachusetts where, although traffic is gradually returning to normal, COVID-19 cases are steady or declining.” 

The team speculated that states with increasing traffic but little increase in COVID-19 cases may offer insights on what policies or guidelines are showing the greatest success at keeping new COVID-19 cases low while emerging from lockdown.

The researchers caution that the analysis remains preliminary and is sensitive to the veracity and comprehensiveness of testing and reporting. Final analysis will be included in a future scientific publication.


Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.

Showing results

110 of 2816